A medicine that raises norepinephrine can sharpen focus. A medicine that activates a norepinephrine receptor can feel calming. Both are true, because norepinephrine is not one signal with one meaning.
Part 3 of the Brain Chemistry series. New here? Start with Your Brain Is Not a Gas Tank, the short orientation that explains the four questions every article in this series answers.
What to know
- Norepinephrine, also called noradrenaline, helps the brain manage alertness, attention, and response to change. Epinephrine, its close relative, mainly works as a hormone released into the bloodstream during the body’s alarm response.
- ADHD medicines reach this system in very different ways: some block the transporter that clears norepinephrine, some also affect dopamine, and some activate a receptor directly instead.
- Centanafadine (brand name Simtriyo) is FDA approved for ADHD, but it is not yet lawfully marketable. Its statutory approval date depends on a separate DEA scheduling notice that had not been issued as of this writing.
- Guanfacine and clonidine can cause a dangerous rebound rise in blood pressure and heart rate if stopped suddenly. Never stop them without a clinician’s plan.
- No blood test, urine test, or gene test can measure the norepinephrine in your brain circuits. A medicine that helps focus does not prove a shortage existed beforehand.
The short answer
Norepinephrine is a chemical messenger. In the brain, most of it comes from a small cluster of cells in the brainstem called the locus coeruleus, whose branches reach widely into the cortex and other regions. It helps brain networks adjust alertness, attention, and how strongly the brain reacts to something new or important. Norepinephrine is also released by nerves throughout the body as part of everyday autonomic function.
Epinephrine, also called adrenaline, is a close chemical cousin. It acts at the same family of receptors as norepinephrine, but its main role in daily life is different: the adrenal glands release it into the bloodstream during the body’s alarm response, coordinating heart rate, blood vessels, and airways all at once. Small groups of epinephrine-producing cells exist in the brainstem too, but epinephrine is far less prominent there than norepinephrine.1
ADHD medicines reach this system at several different points. Some block the transporter that clears norepinephrine away. Some do that and affect dopamine as well. Others skip the transporter entirely and activate a receptor directly, producing a calming effect rather than a stimulating one. More norepinephrine signaling is not automatically better, and less is not automatically worse. No routine test can diagnose a psychiatric condition by reading a norepinephrine level.
Alertness and flexible attention. Norepinephrine from the locus coeruleus reaches broad parts of the cortex, thalamus, and other regions, helping the brain notice and respond to change. It is not simply an energy chemical. Sleep, dopamine, and several other systems shape attention alongside it.
Working memory and focus, under some conditions. Norepinephrine acting at a specific receptor, alpha-2A, can help the prefrontal cortex hold task-relevant information in mind. During severe stress, too much catecholamine activity can shift signaling toward a different receptor and weaken that same control. This is a useful pattern to know, but it does not define one person’s ideal chemical level or prove an ADHD deficiency.2
Body alarm and autonomic control. This part is well established. Nerves release norepinephrine near organs, and the adrenal glands release epinephrine into the blood. Together, these signals can raise heart rate, change blood vessel tone, open airways, and redirect blood flow. A racing pulse or sweating does not reveal which of the two chemicals caused it.
Memory under arousal. Norepinephrine signaling can influence which events get noticed and remembered, but timing, receptor type, and emotional context all matter. Stronger arousal does not automatically mean better memory.
Fear, anxiety, and trauma-related symptoms. Norepinephrine is part of the brain’s stress and arousal networks, and medications that affect it can help selected symptoms. This does not show one global excess of norepinephrine in anxiety or post-traumatic stress disorder. A 2013 imaging study that is sometimes cited on this point was retracted by its journal in 2020 and should not be treated as evidence.4
Meet the adrenergic targets
| Receptor or target | What it does, where it matters, and why you might care |
|---|---|
| Alpha-1 receptors | What it does: Usually activate a cell. Where it matters: Brain, blood vessels, urinary tract. Why you might care: Alerting effects in some brain circuits; also controls blood vessel tone and standing blood pressure. Prazosin blocks this receptor. |
| Alpha-2 receptors | What it does: Usually reduce signaling; can limit how much transmitter a cell releases. Where it matters: Brainstem, prefrontal cortex, sympathetic nerve endings. Why you might care: Relevant to ADHD medicines that work by calming rather than stimulating; guanfacine and clonidine activate this receptor. |
| Beta receptors | What it does: Usually activate a cell. Where it matters: Heart, lungs, blood vessels, and some brain sites. Why you might care: Drive pulse, tremor, and breathing changes during the body’s alarm response. |
| NET (the norepinephrine transporter) | What it does: Returns norepinephrine to the nerve ending that released it. Where it matters: Locus coeruleus projections, cortex, sympathetic nerves. Why you might care: Blocking it extends how long norepinephrine stays active. This is the main target of atomoxetine, viloxazine, and some other ADHD medicines. |
Alpha-2 receptors are a good example of why location changes everything. On a norepinephrine-releasing nerve ending, an alpha-2 receptor acts as a brake, reducing further release. On a prefrontal brain cell, the same receptor type changes how that network processes information. The same drug can lower blood pressure through one location and improve attention through the other, at the same time.2
Can norepinephrine or epinephrine be measured?
Each available method measures a narrow slice, not a whole picture.
Research brain scans can estimate how much of the norepinephrine transporter is available in a given region, and how much of it a drug is occupying. One study of healthy adults found that a clinically relevant dose of methylphenidate did occupy the transporter as expected.3 But occupying the target did not show who had ADHD or who would improve. Occupancy and benefit are two different questions.
Blood or urine tests can measure norepinephrine, epinephrine, or their breakdown products. Clinicians use these tests for specific medical questions, including evaluation of a rare catecholamine-producing tumor. Collection conditions, stress, exercise, caffeine, and other medicines can all shift the results.12 None of this reads norepinephrine activity inside a living attention circuit.
Genetic testing can sometimes explain how a person metabolizes a specific drug. A gene called CYP2D6 can affect exposure to atomoxetine, for example. That is a drug-metabolism answer, not a norepinephrine level and not a guarantee of how well a medicine will work. No validated blood, urine, saliva, hair, scan, or commercial neurotransmitter panel can choose a psychiatric medicine by measuring brain norepinephrine.
What each medicine actually touches
| Medicine | What it does directly, used for, and main tradeoffs |
|---|---|
| Atomoxetine (Strattera) | What it does directly: Blocks the norepinephrine transporter (NET). Used for: ADHD, in adults and children age 6 and up. Main tradeoffs: Boxed warning for suicidal thoughts in children and adolescents; also affects pulse, blood pressure, appetite, and liver function. |
| Viloxazine extended-release (Qelbree) | What it does directly: Blocks NET; also partly activates a serotonin receptor. Used for: ADHD, in adults and children age 6 and up. Main tradeoffs: Boxed warning for suicidal thoughts; pulse, blood pressure, sleepiness, and important drug interactions through a liver enzyme it strongly affects. |
| Methylphenidate | What it does directly: Blocks NET and the dopamine transporter together. Used for: ADHD; narcolepsy, depending on the product. Main tradeoffs: Appetite, sleep, pulse, blood pressure, and misuse risk; a federally controlled Schedule II medicine. |
| Guanfacine extended-release (Intuniv) | What it does directly: Directly activates alpha-2A receptors. Used for: ADHD, alone or with a stimulant. Main tradeoffs: Sleepiness, low blood pressure, slow pulse, and a dangerous rebound rise in blood pressure and heart rate if stopped abruptly. |
| Clonidine extended-release | What it does directly: Directly activates alpha-2 receptors, reducing outgoing sympathetic signals. Used for: ADHD, alone or with a stimulant. Main tradeoffs: Same rebound-hypertension risk as guanfacine if stopped abruptly, plus sleepiness and low blood pressure. |
| Prazosin | What it does directly: Blocks alpha-1 receptors. Used for: FDA approved for high blood pressure; sometimes used off-label for PTSD-related nightmares. Main tradeoffs: A large trial in veterans found no overall benefit for nightmares or sleep quality. Current VA and Department of Defense guidance suggests it may help nightmares specifically, but recommends against using it for overall PTSD symptoms. |
| Centanafadine extended-release (Simtriyo) | What it does directly: Blocks the transporters for norepinephrine, dopamine, and serotonin together. Used for: ADHD. Main tradeoffs: Two boxed warnings, for suicidal thoughts in young people and for misuse, abuse, and addiction. Contraindicated with MAOI antidepressants. FDA approved the application, but the drug is not yet lawfully marketable pending a separate DEA scheduling decision. |
FDA approval, DEA drug scheduling, lawful marketing, and pharmacy availability are four separate events, and centanafadine shows exactly why that distinction matters. FDA issued an approval letter for Simtriyo, but the letter itself states that the drug’s statutory approval date will be the date of a future DEA scheduling notice, and that marketing must wait for that notice plus a labeling update.10 As of this writing, no DEA scheduling notice had been issued. An FDA approval letter is not the same thing as a medicine you can legally buy at a pharmacy.
Prazosin carries its own lesson about how a real receptor action and a real clinical answer can diverge. Blocking alpha-1 receptors is an established, direct effect. Whether that helps PTSD nightmares specifically, versus PTSD symptoms broadly, is a separate question the evidence answers differently for each.59
Why benefit and side effects come from the same system
Follow atomoxetine through the system: it blocks NET. Norepinephrine lingers longer wherever that transporter normally works, which is not just in attention circuits. It also affects pulse and appetite, because NET does its job throughout the body, not only in the brain.
Follow guanfacine instead: it directly activates alpha-2A receptors. In the prefrontal cortex, that can support attention. In the sympathetic nervous system, the same activation lowers blood pressure and heart rate, which is why sleepiness and dizziness are common early effects.
One target, several destinations, different clocks. A side effect showing up does not mean a medicine is failing, and it does not mean it is correcting a deficiency. It means the target sits in more than one place.
What people may notice over time, and the risk of stopping suddenly
A transporter or receptor can change within hours of a first dose. Whether daily function improves takes longer to become clear, and depends on real-life tasks over days and weeks, not the first dose alone. Early effects can include appetite change, dry mouth, nausea, sleepiness or trouble sleeping, dizziness, or a change in pulse or blood pressure.
With repeated use, the body can adapt. Tolerance means an effect gets smaller over time. Dependence means the body has adjusted, so stopping can cause symptoms; it is not the same thing as addiction. Rebound means a symptom briefly rises above where it started after a medicine’s effect wears off or is stopped.
This last point matters most for guanfacine and clonidine. Stopping either one abruptly can trigger a rebound rise in blood pressure and heart rate that is clinically dangerous.7 Stimulants carry their own risks of misuse, dependence, and overdose. There is no single timeline that fits everyone. Always ask the prescriber what to do about a missed dose or an interruption before it happens.
Which symptoms need a call, and which need urgent help
Track and mention at your next visit: appetite or sleep changes, dry mouth, nausea, mild dizziness, sleepiness, sweating, headache, or a clinician-monitored change in pulse or blood pressure.
Call the prescriber or pharmacist promptly: fainting or near-fainting, persistent palpitations, a concerning blood pressure change, new agitation or mania, hallucinations, a severe mood change, or any interruption in guanfacine or clonidine that was not planned with your clinician.
Call Poison Control at 1-800-222-1222 for a suspected overdose or possible poisoning. Do not wait for symptoms to appear. Store any stimulant medicine securely and never share it.
Call 911 now for collapse, seizure, trouble breathing, facial or throat swelling, inability to wake, severe chest pain, signs of stroke, or dangerously high fever with severe agitation. Centanafadine can contribute to serotonin syndrome when combined with another serotonergic drug, which is one reason its rapidly worsening agitation, fever, or muscle stiffness needs emergency evaluation.11 For a suicidal or mental health crisis, call or text 988. If danger is immediate, call 911.
What to ask your prescriber
These are conversation starters, not instructions.
- Which symptom or daily function is this medicine meant to change?
- Does it act directly on the norepinephrine transporter, an alpha-2 receptor, dopamine, or something else?
- What improvement should we look for first, and by when?
- Which pulse, blood pressure, sleep, or mood changes matter for this specific drug?
- What should I do if I miss a dose, or if treatment gets interrupted?
- Could stopping suddenly cause rebound, withdrawal, or a return of symptoms?
- If prazosin comes up, is the goal nightmares specifically or overall PTSD symptoms, since the evidence differs for each?
- If centanafadine (Simtriyo) comes up, has DEA scheduling and lawful marketing actually been confirmed by that point?
Bottom line
A diagnosis does not prove your norepinephrine was too high or too low. Neither does a medicine that helps. As Why Two Opposite Medicines Both Target Dopamine shows for dopamine, one messenger doing several jobs in several places is the rule here, not the exception. See Your Brain Is Not a Gas Tank for why that pattern holds across brain chemistry generally.
Norepinephrine tunes attention and alertness in the brain while helping coordinate the body’s alarm response outside it. ADHD medicines, alpha-2 agonists, and prazosin all reach different parts of that system, which is why very different-feeling medicines can each have a real, defined effect. Ask what a medicine touches directly, what to watch for, and what happens if a dose is missed or a medicine is stopped.
Frequently asked questions
Does ADHD mean I have low norepinephrine?
No. ADHD is diagnosed from a developmental pattern of symptoms and impairment, not a transmitter test. A medicine’s target does not prove what caused the condition.
Are norepinephrine and adrenaline the same thing?
No, but they are close relatives that act on the same receptor families. Norepinephrine is the main messenger discussed in psychiatric brain circuits. Epinephrine’s larger role is as a hormone released into the bloodstream during the body’s alarm response.
Why can a medicine that activates a receptor feel calming instead of stimulating?
Activating a receptor does not mean activating the whole person. Alpha-2 receptors, when activated, typically reduce transmitter release and outgoing sympathetic signals in the locations where guanfacine and clonidine act.
Why do stimulant and non-stimulant ADHD medicines feel so different?
Their targets differ. Methylphenidate affects the norepinephrine and dopamine transporters together. Atomoxetine mainly blocks the norepinephrine transporter. Guanfacine activates a receptor directly instead. Centanafadine affects three transporters at once.
Is centanafadine (Simtriyo) available at pharmacies now?
Not necessarily. FDA approved the application, but the drug’s statutory approval, and lawful marketing, depend on a separate DEA scheduling notice.10 Ask your prescriber or pharmacist about current availability before assuming this medicine is an option.
Why can stopping guanfacine or clonidine suddenly be dangerous?
The cardiovascular system adapts to these medicines during treatment. Stopping abruptly can let blood pressure and heart rate rebound upward. This needs a clinician-guided taper, not a decision made alone.
Does prazosin work for PTSD?
It depends on which symptom. A large trial in veterans found no overall benefit for nightmares or sleep quality, but current VA and Department of Defense guidance still suggests it may help nightmares specifically, while recommending against its use for overall PTSD symptoms.59
Related reading on NP FADY
- Your Brain Is Not a Gas Tank (start here)
- Why Two Opposite Medicines Both Target Dopamine
- The Stress Chemical That Is Not Cortisol
- The Tiny Signals Behind a Dangerous Food Rule
- ADHD Medications Compared: Stimulants vs. Non-Stimulants for Kids and Adults
References
1. Fernandes et al. Noradrenaline regulation of brain-body communication. 2025. PMID: 40442382
2. Arnsten. Catecholamine influences on dorsolateral prefrontal cortical networks. 2011. PMID: 21489408
3. Hannestad et al. Human norepinephrine-transporter occupancy by methylphenidate. 2010. PMID: 20691429
4. Retraction notice, 2013 PTSD locus coeruleus PET report. 2020. PMID: 32074384
5. Raskind et al. Large veteran prazosin trial. 2018. PMID: 29414272
6. Atomoxetine (Strattera) prescribing information. FDA, revised June 2026. Accessed August 31, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021411s053lbl.pdf
7. Guanfacine extended-release (Intuniv) prescribing information. DailyMed, revised June 2025. Accessed August 31, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b972af81-3a37-40be-9fe1-3ddf59852528
8. Viloxazine extended-release (Qelbree) prescribing information. DailyMed. Accessed August 31, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedf408d-0f84-418d-9416-7c39ddb0d29a
9. 2023 VA/DoD prazosin recommendation summary. Accessed August 31, 2026. https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp
10. Centanafadine (Simtriyo) NDA 218145 approval letter. FDA, July 24, 2026. Accessed August 31, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/218145Orig1s000ltr.pdf
11. Centanafadine (Simtriyo) prescribing information. FDA, 2026. Accessed August 31, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218145s000lbl.pdf
12. MedlinePlus. Catecholamine tests. 2024. Accessed August 31, 2026. https://medlineplus.gov/lab-tests/catecholamine-tests/
This article is general education. It is not a diagnosis or a treatment plan. Do not start, stop, or change a medicine because of something you read here. Review every prescription, supplement, and substance with your prescriber or pharmacist.
If you or someone you know is in crisis
- Call 911 or go to your nearest emergency room for any life-threatening emergency.
- 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
- Crisis Text Line — text HOME to 741741.
- The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
- National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
- National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
- Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
- San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
- Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
- California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
- NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.